Alcon Laboratories, Inc. Directors Say Novartis Corporation Bid Grossly Inadequate

Reuters -- Novartis AG's offer to buy out minority shareholders in Alcon Inc is "grossly inadequate", independent directors of the eyecare group said on Wednesday, setting the stage for a prolonged battle.